HOMA-IR: Why Insulin Matters More Than Blood Sugar
HOMA-IR: Why Insulin Matters More Than Blood Sugar
Your last annual physical probably included fasting glucose and A1c. It almost certainly did not include fasting insulin. That omission means your doctor tested the smoke but not the fire — and by the time smoke is visible, the fire has been burning for years.
HOMA-IR is a formula that combines your fasting insulin and fasting glucose to estimate how resistant your cells are to insulin. It catches metabolic dysfunction 5 to 10 years before A1c does. It costs about $25 to add to a blood draw. And it might be the single most informative test most people have never heard of.
What it measures, what your number means, and what to do about it.
The Formula: Simple Math, Useful Signal
HOMA-IR stands for Homeostatic Model Assessment of Insulin Resistance. The formula is:
(Fasting Insulin x Fasting Glucose) / 405
Fasting insulin is measured in mIU/L. Fasting glucose is measured in mg/dL. Both come from the same morning blood draw.
The result is a single number that tells you how hard your body is working to keep blood sugar under control. A low HOMA-IR means your cells respond well to insulin — a small amount moves glucose efficiently. A high HOMA-IR means your cells are ignoring insulin’s signal, forcing your pancreas to produce more and more of it just to keep glucose in range.
These are the tiers Protocol uses in our Metabolic Health protocol:
| HOMA-IR | Classification | What It Means |
|---|---|---|
| Below 1.5 | Healthy | Cells are insulin-sensitive. Pancreas is working at normal capacity. |
| 1.5 - 2.5 | Early dysregulation | Insulin is climbing, but glucose is still controlled. This is the intervention sweet spot. |
| Above 2.5 | Insulin resistant | Pancreas is working overtime. Metabolic damage is accumulating. |
That middle tier, 1.5 to 2.5, is where the real opportunity lives. A person with a HOMA-IR of 2.1 might have a fasting glucose of 94 mg/dL and an A1c of 5.3%. Completely normal on paper. No flags on any standard lab panel. But their pancreas is producing roughly twice the insulin it should to maintain those normal glucose numbers. Without HOMA-IR, this person has zero warning.
Why Your Annual Physical Tests the Wrong Thing
Standard metabolic screening relies on two markers: fasting glucose and A1c. Both measure glucose, the end product. Neither measures insulin, the hormonal signal that controls glucose.
This is like checking the water level in your basement without checking whether your sump pump is working. The water level might be fine right now. But if the pump is running at 200% capacity to keep it fine, you have a problem that a water-level check will never catch — until the pump fails and the basement floods.
Insulin resistance follows the same pattern:
Years 1-5: Cells become less responsive to insulin. Pancreas increases output to compensate. Fasting insulin rises above 8 mIU/L. Fasting glucose: normal. A1c: normal. HOMA-IR: 1.5-2.5. No standard test flags anything.
Years 5-10: Insulin keeps climbing. Fasting insulin may hit 12-20 mIU/L. HOMA-IR crosses above 2.5. Post-meal blood sugars start running higher, but fasting glucose and A1c are still within the “normal” reference range, or just barely outside it.
Year 10+: The pancreas can no longer keep up. Fasting glucose finally rises. A1c crosses 5.7%. Your doctor says “prediabetes.” But the metabolic dysfunction has been present for a decade.
A1c is a late marker. Fasting insulin and HOMA-IR are early markers. Catching this at year 1 versus year 10 is the difference between a few targeted lifestyle changes and a chronic disease management plan.
For a deeper comparison of these two tests, including when each is most useful, read What Fasting Insulin Tells You That A1c Misses.
The Fasting Insulin Ranges Most Doctors Won’t Give You
Most labs set their “normal” reference range for fasting insulin based on population averages. In a population where over 40% of adults have some degree of insulin resistance, the average is not the same as optimal.
A lab might report a fasting insulin of 14 mIU/L as “within normal limits.” A more clinically useful framework:
| Fasting Insulin (mIU/L) | Assessment |
|---|---|
| Below 5 | Optimal — highly insulin-sensitive |
| 5 - 8 | Healthy — normal sensitivity |
| 8 - 12 | Early dysregulation — insulin rising, glucose still controlled |
| Above 12 | Elevated — likely insulin resistant, even with a “normal” A1c |
A fasting insulin of 10 with an A1c of 5.3 is a person whose standard labs look clean. But that insulin level tells you their cells are already less responsive. This is the window when targeted intervention — post-meal movement, protein-first meal sequencing, resistance training, sleep optimization — works best.
Wait until A1c catches up, and the interventions get harder and the stakes get higher.
TG:HDL Ratio: A Free Proxy You Already Have
If you’ve had a standard lipid panel, you already have a surrogate marker for insulin resistance sitting in your results: your TG:HDL ratio, triglycerides divided by HDL cholesterol.
| TG:HDL Ratio | Assessment |
|---|---|
| Below 1.0 | Optimal insulin sensitivity |
| 1.0 - 2.0 | Healthy |
| 2.0 - 3.5 | Possible early insulin resistance |
| Above 3.5 | Strongly associated with insulin resistance |
TG:HDL is less precise than HOMA-IR, but it costs nothing extra — the numbers are already on your lipid panel. If your TG:HDL ratio is above 2.0 and you’ve never had fasting insulin tested, that alone is reason to add it to your next blood draw.
In Protocol’s Metabolic Health protocol, we use TG:HDL as one of the stratification criteria alongside HOMA-IR, fasting insulin, and A1c. Members with a TG:HDL above 2.0 and a HOMA-IR between 1.5 and 2.5 are classified as Tier B — early dysregulation — regardless of whether their A1c looks normal.
The Cancer Connection: Insulin as a Growth Factor
Most people associate insulin resistance with diabetes risk. That’s the most direct consequence. But elevated fasting insulin carries a second, less discussed risk.
Insulin is a growth factor. It promotes cell proliferation. When insulin levels are chronically elevated, cells prone to uncontrolled growth receive a sustained proliferative signal.
The associations between hyperinsulinemia and cancer risk are strongest for:
- Breast cancer — elevated insulin is associated with increased risk in both pre- and postmenopausal women
- Colorectal cancer — insulin resistance is an established risk factor
- Pancreatic cancer — long-standing insulin resistance and type 2 diabetes are strongly associated with increased risk
- Endometrial cancer — hyperinsulinemia is associated with increased risk independent of obesity
These are associations, not proof of causation. The relationships involve obesity, inflammation, and other intertwined factors. But the implication is straightforward: driving fasting insulin down and improving HOMA-IR may reduce risk across multiple disease categories, not just metabolic ones.
If insulin has been elevated for 10 years before A1c finally catches it, that’s 10 years of elevated growth signaling to every cell in your body. Early detection through HOMA-IR isn’t only about preventing diabetes. It’s about reducing a systemic risk signal that touches multiple organ systems.
What to Do With Your Numbers
If you’ve never had fasting insulin tested:
Get it. Ask your doctor to add it to your next blood draw, or order it through a direct-to-consumer lab — Quest, Labcorp, and several online services offer it for $25-40 without a doctor’s order in most states. Get fasting insulin and fasting glucose from the same draw. Calculate your HOMA-IR. Check your TG:HDL ratio from your most recent lipid panel.
If your HOMA-IR is below 1.5:
You’re insulin-sensitive. Retest annually. Whatever you’re doing, keep doing it.
If your HOMA-IR is 1.5 - 2.5 (early dysregulation):
This is the optimal intervention window. The changes that matter most:
- Post-meal walks — 15 minutes after your largest meal. Skeletal muscle contraction moves glucose out of the bloodstream without requiring additional insulin. It’s the simplest, most effective glucose-disposal tool available.
- Protein-first meal sequencing — eat protein and vegetables before starches at each meal. This slows gastric emptying and blunts the post-meal glucose spike.
- Resistance training — 2-3 sessions per week. Muscle is the primary glucose disposal organ. More muscle mass means a larger glucose sink and lower insulin demand.
- Sleep optimization — 7+ hours per night. A single week of sleeping 5 hours per night reduces insulin sensitivity by 25-30%. Sleep is a metabolic intervention, full stop.
- 14-day CGM wear — a continuous glucose monitor tracks your glucose in real time and identifies your specific trigger foods and patterns. Protocol uses this in the Metabolic Health protocol to run paired experiments: same meal, one variable changed.
These interventions can move HOMA-IR from the early dysregulation range back into the healthy range within 60-90 days. Retest at 60 days to confirm the trajectory.
If your HOMA-IR is above 2.5:
You have established insulin resistance. The same interventions apply, but with more intensity and closer monitoring. A structured, coached approach — with specific targets, defined retesting intervals, and clinical oversight — makes the difference between meaningful improvement and spinning your wheels.
If your A1c has already crossed 5.7, read Your A1c Is 5.8 — Now What? for the immediate action plan.
How Protocol Measures This
Fasting insulin and HOMA-IR are not add-ons in our system. They’re the primary stratification tool for every member entering the Metabolic Health protocol. Before a continuous glucose monitor is placed, before any dietary intervention is prescribed, we calculate HOMA-IR and assign a tier:
- Tier A (HOMA-IR below 1.5): Metabolically healthy. The CGM is used for optimization and biofeedback — identifying your top glucose-spiking meals and running targeted experiments.
- Tier B (HOMA-IR 1.5-2.5): Early dysregulation. The CGM is diagnostic and behavioral — we build anchor meals, prescribe post-meal movement, and co-prescribe resistance training as a metabolic intervention.
- Tier C (HOMA-IR above 2.5): Insulin resistant. The CGM is clinical — paired with a structured dietary intervention, a registered dietitian, and MD oversight.
The tier determines everything: encounter frequency, intervention intensity, follow-up cadence, and escalation criteria. A member with a HOMA-IR of 1.2 and a member with a HOMA-IR of 3.1 don’t get the same protocol — because they don’t have the same problem.
That specificity starts with a $25 test most annual physicals skip.
Ready to find out where you stand? Protocol’s Foundation Assessment measures what your annual physical misses — ApoB, HOMA-IR, DEXA body composition, VO2 max — and builds a specific action plan from the data.